首页> 美国卫生研究院文献>AAPS PharmSciTech >Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism
【2h】

Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism

机译:Eudragit®RL和L-55混合物的涂层:药物释放机理的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In a previous study, generally lower drug release rates from RL:L55 blend coated pellets in neutral/basic release media than in acidic release media were reported. The aim of this study was to obtain information on the drug release mechanism of solid dosage forms coated with blends of Eudragit® RL (RL) and Eudragit® L-55 (L55). Swelling experiments with free films were analyzed spectroscopically and gravimetrically to identify the physicochemical cause for this release behavior. With Raman spectroscopy, the swelling of copolymer films could be monitored. IR spectroscopic investigations on RL:L55 blends immersed in media at pH 6.8 confirmed the formation of interpolyelectrolyte complexes (IPECs) that were not detectable after swelling in hydrochloric acid pH 1.2. Further investigations revealed that these IPECs decreased the extent of ion exchange between the quaternary ammonium groups of RL and the swelling media. This is presumably the reason for the previously reported decreased drug permeability of RL:L55 coatings in neutral/basic media as ion exchange is the determining factor in drug release from RL coated dosage forms. Gravimetric erosion studies confirmed that L55 was not leached out of the film blends during swelling in phosphate buffer pH 6.8. In contrast to all other investigated films, the 4:1 (RL:L55) blend showed an extensive swelling within 24 h at pH 6.8 which explains the reported sigmoidal release behavior of 4:1 blend coated pellets. These results help to understand the release behavior of RL:L55 blend coated solid dosage forms.
机译:在先前的研究中,据报道,在中性/碱性释放介质中,RL:L55共混物包衣的药丸的药物释放速率通常低于酸性释放介质。这项研究的目的是获得有关涂覆有Eudragit ® RL(RL)和Eudragit ® L-55(L55)混合物的固体剂型药物释放机理的信息。 )。用分光光度法和重量分析法对具有游离膜的溶胀实验进行了分析,以确定该释放行为的物理化学原因。利用拉曼光谱法,可以监测共聚物膜的溶胀。对浸入pH值为6.8的介质中的RL:L55共混物进行的红外光谱研究证实,在pH值为1.2的盐酸中溶胀后,无法检测到聚电解质间复合物(IPEC)的形成。进一步的研究表明,这些IPEC降低了RL季铵基团与溶胀介质之间的离子交换程度。推测这是先前报道的RL:L55涂层在中性/碱性介质中药物渗透性降低的原因,因为离子交换是从RL涂层剂型释放药物的决定因素。重量腐蚀研究证实,在pH 6.8的磷酸盐缓冲液中溶胀期间,L55没有从膜混合物中浸出。与所有其他研究过的薄膜相反,4:1(RL:L55)共混物在pH 6.8的24小时内显示出广泛的溶胀,这解释了报道的4:1共混物包覆颗粒的S型释放行为。这些结果有助于了解RL:L55共混物包衣固体剂型的释放行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号